📰 off-dutyCNBCSunday, July 19, 2026 at 2:45 PM UTC4d ago

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health

Read full article at CNBC →

Originally published by CNBC. Summary and curation by DutyStation.ai.

← Back to Military News

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

📰 Related Stories

Amazon cracks down on use of AI images by sellers after New York law

Allianz to buy HSBC’s Singapore insurance unit for $2.09 billion

Meet the judges who will crown Australia’s next breakout startup

Parris Island drill instructor found dead in apartment

Intel's turnaround under CEO Lip-Bu Tan gains steam with another strong quarter

Intel Benefits From a New Shift in A.I. Spending